IL129623A0 - Novel trans-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes - Google Patents

Novel trans-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes

Info

Publication number
IL129623A0
IL129623A0 IL12962397A IL12962397A IL129623A0 IL 129623 A0 IL129623 A0 IL 129623A0 IL 12962397 A IL12962397 A IL 12962397A IL 12962397 A IL12962397 A IL 12962397A IL 129623 A0 IL129623 A0 IL 129623A0
Authority
IL
Israel
Prior art keywords
syndromes
prevention
treatment
related diseases
derivatives useful
Prior art date
Application number
IL12962397A
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of IL129623A0 publication Critical patent/IL129623A0/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/24Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30Oestrogens
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
IL12962397A 1996-10-28 1997-10-28 Novel trans-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes IL129623A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK120196 1996-10-28
PCT/DK1997/000481 WO1998018774A1 (en) 1996-10-28 1997-10-28 Novel trans-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes

Publications (1)

Publication Number Publication Date
IL129623A0 true IL129623A0 (en) 2000-02-29

Family

ID=8102120

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12962397A IL129623A0 (en) 1996-10-28 1997-10-28 Novel trans-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes

Country Status (8)

Country Link
EP (1) EP0937059A1 (en)
JP (1) JP2001502706A (en)
AU (1) AU744403B2 (en)
CA (1) CA2269936A1 (en)
IL (1) IL129623A0 (en)
NO (1) NO992009L (en)
WO (1) WO1998018774A1 (en)
ZA (1) ZA979643B (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998025916A1 (en) * 1996-12-13 1998-06-18 C & C Research Laboratories Novel benzopyran derivatives
KR100615757B1 (en) * 1998-12-30 2006-08-25 시그날 파마소티칼 아이엔씨 Compounds and methods for modulation of estrogen receptors
CN1261431C (en) * 2001-01-24 2006-06-28 奇斯药制品公司 2H-1-benzopyran derivatives, processes for their preparation and pharmaceutical compositions thereof
MX2007003216A (en) 2004-09-21 2008-03-10 Novogen Res Pty Ltd Substituted chroman derivatives, medicaments and use in therapy.
US8080675B2 (en) 2004-09-21 2011-12-20 Marshall Edwards, Inc. Chroman derivatives, medicaments and use in therapy
JP4976649B2 (en) * 2004-09-21 2012-07-18 マーシャル エドワーズ,インク. Compound
WO2012061413A2 (en) 2010-11-01 2012-05-10 Marshall Edwards, Inc. Isoflavonoid compositions and methods for the treatment of cancer
CA2974123C (en) 2015-02-02 2023-08-01 Mei Pharma, Inc. Combination of benzopyran derivative and glycolytic inhibitors for cancer therapy

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3340276A (en) * 1964-04-01 1967-09-05 Ciba Geigy Corp 3, 4-diphenyl-chromans
DE1543749A1 (en) * 1966-02-16 1969-12-11 Merck Ag E Process for the preparation of 3,4-cis-4-aryl-isoflavans
US5280040A (en) * 1993-03-11 1994-01-18 Zymogenetics, Inc. Methods for reducing bone loss using centchroman derivatives
HUP9702244A3 (en) * 1995-01-13 1999-12-28 Novo Nordisk As Use of 3,4-diphenyl chromans for manufacture of a pharmaceutical composition for treatment or prophylaxis of gynaecological disorders

Also Published As

Publication number Publication date
AU4771897A (en) 1998-05-22
NO992009D0 (en) 1999-04-27
ZA979643B (en) 1998-04-28
CA2269936A1 (en) 1998-05-07
NO992009L (en) 1999-06-25
JP2001502706A (en) 2001-02-27
AU744403B2 (en) 2002-02-21
WO1998018774A1 (en) 1998-05-07
EP0937059A1 (en) 1999-08-25

Similar Documents

Publication Publication Date Title
AU4966497A (en) Novel acylamino-substituted acylanilide derivatives or pharmaceutical composition comprising the same
HUP9900790A3 (en) Imidazoquinazoline derivatives
ZA9710322B (en) Process for the preparation of benzyl-ethers.
AU8181798A (en) Adjustable leg
ZA984174B (en) Novel triptolide derivatives useful in the treatment of autoimmune diseases
EP0990632A4 (en) Adamantanemethanol derivatives and process for the preparation thereof
EP0890599A4 (en) Polyorganosiloxazanes and process for the preparation thereof
IL129623A0 (en) Novel trans-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
IL133089A0 (en) Novel triptolide derivatives useful in the treatment of autoimmune diseases
IL129622A0 (en) Novel CIS-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
IL129624A0 (en) Novel (+)-enantiomers of CIS-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
IL129618A0 (en) Novel CIS-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
AU663832B2 (en) Easy chess-like game
IL129626A0 (en) Novel CIS-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
ZA972708B (en) Pharmaceutical compositions and methods for the manufacture thereof.
GB9608657D0 (en) Novel treatment
IL129617A0 (en) Novel CIS-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
GB2322785B (en) Pasteurizing process
HK1004660A1 (en) Composition for treating hyperosteogeny and process for the preparation thereof
GB2302691B (en) Oxaindene derivatives and process for the preparation thereof
AU7639998A (en) Pyrrolo{2,1,5-cd}indolizine derivatives useful in the prevention or treatment ofestrogen related diseases or syndromes
ZA9610708B (en) Oxaindene derivatives and process for the preparation thereof.
ZA984823B (en) Pyrrolo(2,1,5-cd)indolizine derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
ZA984822B (en) Pyrrolo (2,11,5-cd) indolizine derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
ZA975061B (en) Manufacture of articles.